BsADC Market Set to Reach $2B by 2030 as First Drug Approval Looms
Bispecific antibody drug conjugates market projected at $2B+ by 2030, with first approval expected by 2028 amid 150+ global clinical trials.
AMGNAZNGMABclinical trialsmarket opportunity